Repligen (RGEN) EBIT (2016 - 2025)
Historic EBIT for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $16.8 million.
- Repligen's EBIT rose 31482.38% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $798000.0, marking a year-over-year decrease of 9291.3%. This contributed to the annual value of -$35.1 million for FY2024, which is 17360.96% down from last year.
- According to the latest figures from Q3 2025, Repligen's EBIT is $16.8 million, which was up 31482.38% from $13.9 million recorded in Q2 2025.
- Repligen's 5-year EBIT high stood at $63.2 million for Q2 2022, and its period low was -$36.5 million during Q4 2024.
- In the last 5 years, Repligen's EBIT had a median value of $16.8 million in 2025 and averaged $23.3 million.
- Its EBIT has fluctuated over the past 5 years, first tumbled by 46970.53% in 2024, then surged by 31482.38% in 2025.
- Over the past 5 years, Repligen's EBIT (Quarter) stood at $37.4 million in 2021, then soared by 30.47% to $48.8 million in 2022, then crashed by 79.78% to $9.9 million in 2023, then tumbled by 469.71% to -$36.5 million in 2024, then soared by 146.09% to $16.8 million in 2025.
- Its last three reported values are $16.8 million in Q3 2025, $13.9 million for Q2 2025, and $6.6 million during Q1 2025.